The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase III randomized French multicentric study to evaluate the impact of a localized 16-Gy boost after conservative surgery and a 50-Gy whole-breast irradiation in breast ductal carcinoma in situ (the BONBIS trial).
D. Azria
Honoraria - Novartis; Roche
D. Cowen
No relevant relationships to disclose
C. Bourgier
No relevant relationships to disclose
B. de la Lande
No relevant relationships to disclose
S. Gourgou-Bourgade
No relevant relationships to disclose
Z. Douadi Gaci
No relevant relationships to disclose
M. Leblanc-Onfroy
No relevant relationships to disclose
I. Latorzeff
No relevant relationships to disclose
O. Pradier
No relevant relationships to disclose
P. Maingon
No relevant relationships to disclose
I. Lecouillard
No relevant relationships to disclose
P. Bontemps
No relevant relationships to disclose
S. Ellis
No relevant relationships to disclose
C. Levy
No relevant relationships to disclose
A. Benyoucef
No relevant relationships to disclose
S. Racadot
No relevant relationships to disclose
H. Laharie-Mineur
No relevant relationships to disclose
P. Lagarde
No relevant relationships to disclose
C. Marchal
No relevant relationships to disclose
C. Lemanski
No relevant relationships to disclose